Home・Aktien・Repligen Corp

Repligen Corp

Geschlossen

BrancheGesundheitswesen

161.69 2.25

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

154.16

Max

162.13

Schlüsselkennzahlen
By Trading Economics
Einkommen	-3.3M 5M
Verkäufe	9.9M 204M
KGV Branchendurchschnitt	201.452 68.51
EPS	0.54
Gewinnspanne	2.453
Angestellte	2,000
EBITDA	-35M -2.4M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+8.74% upside

Dividenden
By Acuity
Nächstes Ergebnis	27. Okt. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	907M 8.3B
Vorheriger Eröffnungskurs	159.44
Vorheriger Schlusskurs	161.69

Nachrichtenstimmung

By Acuity

20%

80%

46 / 340 Ranking in Healthcare

Repligen Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Repligen Corp Prognose

Kursziel

By TipRanks

8.74% Vorteil

12-Monats-Prognose

Durchschnitt 172.45 USD 8.74%

Hoch 207 USD

Tief 145 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Repligen Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

14 ratings

Buy

Halten

Sell

Basierend auf 14 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Repligen Corp – Dist abgegeben haben.

Stimmung

By Acuity

46 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.